A randomized, double-blind, placebo-controlled phase 2 study evaluating the efficacy and safety of romiplostim treatment of patients with low or intermediate-1 risk myelodysplastic syndrome receiving lenalidomide (Q33404600)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized, double-blind, placebo-controlled phase 2 study evaluating the efficacy and safety of romiplostim treatment of patients with low or intermediate-1 risk myelodysplastic syndrome receiving lenalidomide |
scientific article |
Statements
1 reference
A randomized, double-blind, placebo-controlled phase 2 study evaluating the efficacy and safety of romiplostim treatment of patients with low or intermediate-1 risk myelodysplastic syndrome receiving lenalidomide (English)
1 reference
Eunice S Wang
1 reference
Roger M Lyons
1 reference
Sunil Gandhi
1 reference
Delong Liu
1 reference
Carmen Matei
1 reference
Bart Scott
1 reference
Kuolung Hu
1 reference
Allen S Yang
1 reference
29 November 2012
1 reference
1 reference
29 November 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference